This is an automatically translated article.
Armephapro drug is manufactured and registered by the branch of Armephaco Joint Stock Company - Pharmaceutical Factory 150. What is the effect of Armephapro and how is it used? Please read the following article.
1. What is Armephapro?
Armephapro medicine contains the active ingredient Chlorpheniramine maleate with the strength of 2mg and Pseudoephedrine hydrochloride with the content of 60mg. The drug is prepared in the form of tablets, packing box of 10 blisters, 10 tablets / 1 blister and bottle of 100 tablets.
2. Effects of the drug Armephapro
Effects of the drug Armephapro:
Active ingredient Clopheniramine is an antihistamine with very little sedative effect. Clopheniramine has an anti-acetylcholine side effect like most other antihistamines, but this side effect varies from person to person. The antihistamine effect of clopheniramine is obtained through competitive blockade of H1 receptors of effector cells. Active ingredient Pseudoephedrine through sympathomimetic action has a mechanism of action to reduce congestion (a substance that effectively relieves congestion in the upper respiratory tract). Considering Ephedrine's effects on increasing systolic blood pressure, tachycardia, and central nervous system stimulation, Pseudoephedrine is much weaker. Armephapro is indicated for use in the following cases:
Indicated for the treatment of allergic rhinitis, reducing congestion in the nose and upper respiratory tract. Used to relieve symptoms associated with the common cold and allergic rhinitis such as sneezing, nasal congestion, itching, runny nose, watery eyes. Treatment for cases of skin allergies such as eczema, urticaria.
3. How to use and dosage of Armephapro
How to use Armephapro:
Armephapro is produced in the form of tablets, used orally, regardless of the time of meals. Dosage of the drug Armephapro:
In adults and children > 12 years old: Use 2 to 3 times a day, 1 tablet once. In children from 6 to 12 years old: Use 2 to 3 times a day, 1 time 1⁄2 tablets. Overdose and overdose treatment:
When using Armephapro drug overdose, patients may experience the following symptoms: Dizziness, drowsiness, lethargy, ataxia, decreased tone, feeling of weakness, dry skin and mucous membranes, respiratory failure, high blood pressure, tachycardia, hyperactivity, high fever, convulsions, irritability, dysuria, nausea, vomiting, nystagmus. In severe cases, circulatory failure, cardiac arrest, apnea, and death can occur. It is recommended that patients when using an overdose and experiencing unusual symptoms, should immediately notify the doctor for timely support and treatment.
4. Undesirable effects of the drug Armephapro
During treatment with Armephapro, patients may experience the following undesirable effects:
Dizziness, somnolence, dizziness, dry mouth, nose, throat, nausea, constipation. There have also been some reports of dysuria in male patients receiving Pseudoephedrine, in which prostatic hypertrophy may be an important factor in this effect.
5. Armephapro drug interactions
The anti-acetylcholine effect of Armephapro may be prolonged and increased when used concomitantly with Monoamine Oxidase inhibitors. The CNS depressant effect of Armephapro is increased when co-administered with hypnotic sedatives or Ethanol. Phenytoin when used with Chlorpheniramine will inhibit metabolism and may lead to Phenytoin toxicity. Active ingredient Pseudoephedein may partially reverse the effects of drugs that interfere with sympathomimetic activity such as Gaunethidine, Bethanidine, Methyldopa, Delerisoquine, Bretylium and Adrenergic blocking agents. It is necessary to avoid or limit the use of tobacco, alcohol, alcoholic beverages or fermentation while using Armephapro, as these agents can cause changes in the components of the drug.
6. Notes when using Armephapro
Contraindications of Armephapro:
Armephapro is not contraindicated in patients with a history of hypersensitivity to Chlorpheniramine, Pseudoephedein or any of the excipients contained in the drug. Do not use for subjects with acute asthma, symptoms of prostate enlargement, bladder neck obstruction, narrow-angle glaucoma, peptic ulcer and pyloroduodenal obstruction. Do not use for pregnant women and lactating mothers, children under 6 years old. Do not use in patients who have been taking MAOIs within the previous 2 weeks. Do not use for patients who have jobs related to operating machinery or driving because there may be symptoms of dizziness, somnolence, blurred vision, dizziness. Armephapro should be used with caution in the following subjects:
Patients with diabetes, cardiovascular disease, high blood pressure, prostate enlargement, hyperthyroidism, urethral stricture, glaucoma, myasthenia gravis , pyloric obstruction. Patients with chronic obstructive pulmonary disease. Elderly people over 60 years old. The patient is taking tricyclic antidepressants, antihypertensive drugs.
7. Storing Armephapro
Store Armephapro in a cool, dry place, avoid direct sunlight or high temperature because it can change the ingredients in the medicine. N Suitable storage temperature is below 30 degrees Celsius. Keep out of reach of children and pets.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
